Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Inventory Average (2019 - 2025)

Historic Inventory Average for Akebia Therapeutics (AKBA) over the last 7 years, with Q3 2025 value amounting to $17.7 million.

  • Akebia Therapeutics' Inventory Average fell 2031.78% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year decrease of 2031.78%. This contributed to the annual value of $16.0 million for FY2024, which is 1429.18% down from last year.
  • Latest data reveals that Akebia Therapeutics reported Inventory Average of $17.7 million as of Q3 2025, which was down 2031.78% from $18.2 million recorded in Q2 2025.
  • Over the past 5 years, Akebia Therapeutics' Inventory Average peaked at $52.9 million during Q1 2021, and registered a low of $17.1 million during Q4 2023.
  • In the last 5 years, Akebia Therapeutics' Inventory Average had a median value of $22.2 million in 2024 and averaged $28.4 million.
  • As far as peak fluctuations go, Akebia Therapeutics' Inventory Average tumbled by 6287.9% in 2021, and later skyrocketed by 1957.88% in 2024.
  • Akebia Therapeutics' Inventory Average (Quarter) stood at $35.2 million in 2021, then dropped by 4.99% to $33.4 million in 2022, then tumbled by 48.91% to $17.1 million in 2023, then rose by 7.63% to $18.4 million in 2024, then fell by 3.77% to $17.7 million in 2025.
  • Its last three reported values are $17.7 million in Q3 2025, $18.2 million for Q2 2025, and $18.0 million during Q1 2025.